RHEUMATOID ARTHRITIS-MANAGEMENT (OTHER NON BIOLOGIC DMARDs)

From NeuroRehab.wiki

Revision as of 11:30, 1 January 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Leflunomide: pyrimidine antagonist and may be used as an initial DMARD in patients unable to take MTX. SE: diarrhea, respiratory infections, hepatotoxicity, teratogenicity.
2. Hydroxychloroquine. SE: retinopathy, patients require baseline optometry prior to commencing the drug.
3. Sulfasalazine. SE: sulfa-allergic reactions, myelosuppression, GI disturbance.


Reference(s)

Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

Retrieved from "https://www.neurorehab.wiki/index.php?title=RHEUMATOID_ARTHRITIS-MANAGEMENT_(OTHER_NON_BIOLOGIC_DMARDs)&oldid=14024"